Clinical Trial Update: Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nivolumab to investigator's choice therapy in recurrent/metastatic squamous cell carcinoma of the head and neck completed with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Status: COMPLETED | Results posted: 2017-01-11